Skip to Main Content
Share
Help
Email
Print
Close Window
National Coverage Analysis (NCA) for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R4)
Contact(s)
Jeffrey Roche, MD, MPH
Stuart Caplan RN, MAS
stuart.caplan@cms.hhs.gov
410-786-8564
Back to Top
Documents
Tracking Sheet
Proposed Decision Memo
View Public Comments
NCD for Positron Emission Tomography (PET) Scans (220.6)
Back to Top
History of Considerations
Original Consideration for Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers (CAG-00181N)
First reconsideration for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R)
Second reconsideration for Positron Emission Tomography (FDG) for Cervical Cancer (CAG-00181R2)
Third reconsideration for Positron Emission Tomography for Initial Treatment Strategy in Solid Tumors and Myeloma (CAG-00181R3)
Fourth reconsideration for Positron Emission Tomography (FDG) for Solid Tumors (this document)
Back to Top
Footer Links
Get Help with File Formats and Plug-Ins
Submit Feedback
www